Home › Compare › MDVLQ vs JEPQ

MDVLQ vs JEPQ: Dividend Comparison 2026

MDVLQ yields 2000000.00% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDVLQ wins by $4.879226400974806e+39M in total portfolio value
10 years
MDVLQ
MDVLQ
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full MDVLQ calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — MDVLQ vs JEPQ

📍 MDVLQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDVLQJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDVLQ + JEPQ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MDVLQ pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDVLQ
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, MDVLQ beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDVLQ + JEPQ for your $10,000?

MDVLQ: 50%JEPQ: 50%
100% JEPQ50/50100% MDVLQ
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDVLQ buys
0
JEPQ buys
0
No recent congressional trades found for MDVLQ or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDVLQJEPQ
Forward yield2000000.00% ✓11.10%
Annual dividend / share$2.00$6.16 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.879226400974806e+39M$44.8K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$2,152.59
Total dividends collected$4.879195005460081e+39M$16.3K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: MDVLQ vs JEPQ ($10,000, DRIP)

YearMDVLQ PortfolioMDVLQ Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,930$1,110.39+$200.00M → MDVLQ
2$3,738,731,768,458$3,738,517,757,009.35$14,133$1,224.34+$3738731.75M → MDVLQ
3$65,315,062,866,930,490$65,311,062,423,938,240.00$16,632$1,340.46+$65315062866.91M → MDVLQ
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$19,454$1,457.97+$1066400830062625.00M → MDVLQ
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$22,626$1,576.08+$16272182796453826560.00M → MDVLQ
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$26,175$1,694.09+$2.3205424011366188e+23M → MDVLQ
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$30,133$1,811.32+$3.0927990661046884e+27M → MDVLQ
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$34,531$1,927.17+$3.8524105697352695e+31M → MDVLQ
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$39,403$2,041.08+$4.484688260147987e+35M → MDVLQ
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$44,787$2,152.59+$4.879226400974806e+39M → MDVLQ

MDVLQ vs JEPQ: Complete Analysis 2026

MDVLQ — Stock

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Full MDVLQ Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this MDVLQ vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDVLQ vs SCHDMDVLQ vs JEPIMDVLQ vs OMDVLQ vs KOMDVLQ vs MAINMDVLQ vs XYLDMDVLQ vs QYLDMDVLQ vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.